Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Yorkshire Terriers with Colour Dilution Alopecia have reduced melanin and hair structure issues.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Two patients had a unique form of trichothiodystrophy with reduced high-sulfur proteins in their hair.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Diphencyprone therapy for hair loss can cause vitiligo.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Hair-Thread Tourniquet Syndrome is a rare condition where hair or thread tightly wraps around a child's body part, requiring quick treatment to prevent damage.

Hepatitis C and alcohol abuse may lead to porphyria cutanea tarda.

A young woman had a rare scalp tumor usually found in older women.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

PDI helps restore over-bleached hair's strength and structure by attaching special peptides.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

DPR can show different hair characteristics, as seen in two brothers with normal hair.

DCP in isopropanol is better tolerated for treating alopecia areata.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

The inhibitor DPP can promote hair growth.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.